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Iodine is an effective, simple, and cost-efficient means ofwater disinfection forpeople who vaca-
tion, travel, or work in areas where municipal water treatment is not reliable. However, there is
considerable controversyabout themaximum safe iodine dose and duration ofusewhen iodine is
ingested in excess ofthe recommended daily dietary amount. The major health effect ofconcern
with excess iodine ingestion is thyroid disorders, primarily hypothyroidism with or without
iodine-induced goiter. Areviewofthe humantrials on thesafetyofiodine ingestion indicates that
neither the maximum recommended dietary dose (2 mg/day) nor the mum recommended
duration ofuse (3 weeks) has a firm basis. Rather than a clear threshold response level or a linear
and temporal dose-response relationship between iodine intake and thyroid function, there
appears to be markedindividualsensitivity, often resultingfromunmasking ofunderlyingthyroid
disease. The use ofiodine forwaterdisinfection requires arisk-benefit decision based on iodine's
benefit as a disinfectant and the changes it induces in thyroid physiology. By using appropriate
disinfection techniques and monitoring thyroid finction, most people can use iodine for water
treatment over a prolonged period oftime. Key worni goiter, iodine, thyroid disorders, thyroid
hormones, water purification, water supply. Environ Healtb Perspect 108:679-684 (2000).
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Iodine is an essential nutrient for optimal thy-
roid function in adults and for fetal, infant,
and child development. Dietary supplementa-
tion, generally via iodized salt but occasionally
via iodinated water, has decreased goiter and
hypothyroidism due to iodine deficiency in
most of the world. Data from supplementa-
tion programs and elsewhere indicate that
adults need to ingest at least 150-200 pg
iodine per day (1-3). Hollowell et al. (4)
reported that the average American intake of
iodine is near optimal. Nonetheless, inges-
tion ofiodine in excess ofthe recommended
daily intake level is common because of
iodine in dietary sources such as dairy, eggs,
meat, bread, and seaweed, or that in phar-
macologic sources such as the cardiac antiar-
rhythmic drug amiodarone. Excess iodine
may also disrupt normal thyroid function,
but the maximum safe level for long-term
ingestion remains undetermined. Experts
suggest that 1-2 mg/day is safe for most
people, yet empiric evidence suggests that
much higher amounts are usually tolerated
without problems (1,5).
The use of iodine to improve the micro-
biologic quality of drinking water in areas
without safe public sources of potable water
also contributes iodine levels in excess ofthe
recommended maximum daily intake. Field
water treatment is a necessity for millions of
travelers, campers, military troops, and peo-
ple living and working in underdeveloped
areas, in addition to entire populations in
disaster and medical relief situations (6). We
reviewed published data on the effects of
consuming more than the daily recom-
mended dose of iodine in an attempt to
identify the maximum safe dose and dura-
tion of ingestion when iodine is used for
water disinfection.
Iodine for Water Treatment
Iodine is a halogen, like chlorine, that exerts
a biocidal effect through its chemical proper-
ty as a strong oxidant. The active disinfectant
species are elemental iodine and hypoiodous
acid (7,8). Iodide has no disinfectant activity;
however, iodine is rapidly converted to
iodide in the stomach and absorbed into the
blood. Water disinfection with halogens is a
first-order chemical reaction: the primary
variables are aqueous concentration of halo-
gen and the time it is in contact with the
microorganism (9,10). In addition, different
classes of microorganisms vary in their sus-
ceptibility to halogens. Bacteria are very sen-
sitive, viruses are intermediate, and protozoan
cysts are more resistant. Doses of iodine
below 1 mg/L are effective for bacteria within
minutes; however, at this concentration, it
would take many hours to kill Giardia cysts.
Although low doses can be used in controlled
situations, recommended levels of iodine for
point-of-use water disinfection in unmoni-
tored field situations are higher to allow for
unanticipated reactions with organic contam-
inants (halogen demand) and to allow a rela-
tively short contact time (6).
Iodine has several advantages over chlo-
rine for field use-including greater chemical
stability of the product and less reactivity
with organic nitrogenous contaminants of
residual concentrations in water-leaving
higher free residual concentration in water
and more acceptable taste in equipotent
doses (11,12). Iodine is available in a variety
of forms, including solutions (tincture of
iodine, povidone, Lugol's, and saturated
aqueous solution with iodine crystals),
tablets, and iodine resins.
Iodine resins offer additional advantages
for field use because the resins are an
extremely stable form of iodine that can be
incorporated into a wide range offilters and
act as a demand disinfectant with limited
dissolution in water (13). Little iodine is
released into aqueous solution, however: as
water passes through and microorganisms
contact the resin, iodine is aided by electro-
static forces and binds to microorganisms.
The residual iodine concentration with
iodine resins is much less than concentra-
tions from the recommended doses oftablet
or liquid forms of iodine (Table 1). Iodine
resin filters usually incorporate two addi-
tional stages: microfiltration to remove
Cryptosporidium oocysts that are resistant to
halogen disinfection, and granular activated
charcoal to further reduce the concentration
ofiodine in effluent water.
Iodine has been used to ensure the safety
of potable water since the 1940s, when the
military developed a tablet formulation for
use by troops in the field (10). Widespread
use followed in the civilian population.
There are no accurate figures for the number
of civilian or military personnel who use
iodine for water disinfection. A survey of
manufacturers reveals that in 1998 approxi-
mately 60,000 iodine resin devices were sold
for individual or small-group civilian use. In
addition, the leading manufacturer sold
more than 300,000 bottles ofiodine tablets.
This does not include iodine sold in other
forms, such as tincture of iodine, povidone,
or iodine crystals in aqueous solution.
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Table 1. Residual iodine in demand-free water using recommended doses of available product.
Recommended dose
Iodine products per liter ofwatera Concentration of iodine
Iodine tablets (tetraglycine hydroperiodide) 1-2 tablets 8-16 mg/L
Emergency drinking water germicidal tablet
Potable Aquab
Globalinec
2% iodine solution (tincture) 0.25-0.5 ml(5-10 gtt) 4-8 mg/L
10% povidone-iodine solution 0.35-0.70 mL(8-16 gtt) 4-8 mg/L
Saturated iodine crystals in water
Polar Pured 13-26 mL 4-8 mg/[
Pentaiodide resin at room temperature 1-2 ppm
Triiodiide resin
At room temperature 0.2 ppm
At42`C 1 ppm
At71°C 6-10 ppm
Aftergranular activated charcoal 0.01 ppm
Data from Powers (14) and Marchen and Fina (15). gtt, drops.
kLower dose in clear, warm water(< 15WC), higher dose in very cold or cloudywater. Disinfection efficacy is a function of
iodine concentration and contact time as well as a function of the water temperature. bWisconsin Pharmaceutical,
Jackson, WI. "Van Ben Industries, Long Island, NY. dPolar Equipment, Saratoga, CA.
Because of the ill-defined risk of iodine
affecting thyroid function and because other
means ofwater treatment are often available,
the World Health Organization (WHO)
and the U.S. Environmental Protection
Agency recommend that iodine be used for
short-term or emergency use only for water
treatment (16-18). However, many people
use iodine for much longer periods because
of the convenience and effectiveness of the
products. Despite the extensive use ofiodine
for both pharmacologic preparations and
water disinfection over the past 50 years,
there are remarkably few reports ofresulting
clinical thyroid disorders (159!. Recently, goi-
ters discovered among a group of Peace
Corps volunteers in Africa were linked epi-
demiologically to the use of iodine resin fil-
ters forwaterdisinfection (20).
Thyroid Effects of Excess
Iodine Ingestion
Physiologic effects. The physiologic regulation
of the thyroid gland by iodine is complex,
involving feedback mechanisms at several bio-
chemical and physiologic steps that depend
on the amount of iodine and the rate of
administration. In most instances, these
autoregulatory mechanisms effectively handle
excess iodine intake.
In animal studies, acute iodine adminis-
tration has induced different responses based
on the amount ofiodine. Single lowdoses of
iodine (2.5-50 pg) given intraperitoneally to
rats had little effect on the metabolism of
iodine relative to organification. The accu-
mulation ofiodine by the thyroid gland and
the incorporation of iodine into triiodothy-
ronine (T3) or tetraiodothyronine (T4)
increased proportionately with the dose
received. At serum levels > 50 pg/dL, rats
had decreased uptake of thyroidal iodide,
decreased organification, and decreased pro-
duction ofT3 and T4 from newly iodinated
amino acids (21). With large doses ofiodide,
the iodide accumulation and the absolute
rate of organification both decreased. The
inhibition of iodine organification is called
the Wolff-Chaikoff (W-C) effect. Wolffand
Chaikoff (22) and Wolff et al. (23) further
demonstrated that when rats maintained
high levels ofserum iodine for > 40 hr, the
inhibition ofiodine on organification in the
thyroid ceased and the thyroid resumed its
normal rate ofhormone synthesis, preserving
the euthyroid state.
In humans, iodide intake of > 2 mg/day
results in a proportionate decrease in the
organification ofthyroidal iodide, but there is
no evidence that the overall amount of
organic iodination is decreased (24). There
are adequate data to demonstrate that thyroid
1311 uptake or thyroid clearance of iodide
decreases with increases in serum iodide lev-
els. Studies to limit radioactive iodine uptake
in the event of a nuclear accident or fallout
have demonstrated rapid suppression of
uptake after the administration of iodide
(25,26). Single doses > 10 mg suppress the
uptake ofradioactive iodine to < 1.5% with-
in 24 hr, and daily doses of > 15 mg will
maintain uptake below2% (25).
The limitations of in vivo measurement
make it difficult to demonstrate the same bio-
chemical mechanism of the W-C effect and
escape from it in humans (27). Regardless of
the mechanism, an escape from the inhibito-
ry effects ofprolonged excess levels ofiodine
is also seen in humans. For this reason, most
people can tolerate high doses of iodine
without developing thyroid abnormalities.
Clinical effects. Hyperthyroidism.
Iodine-induced hyperthyroidism can be
caused by underlying thyroid disease or by
the consumption of iodine by people with
prior iodine deficiency (5,28,29). During
the worldwide campaign to eliminate
endemic goiter and associated cretinism,
Stanbury et al. (30) reported that some peo-
ple would develop hyperthyroidism after
receiving only small amounts ofiodine sup-
plements. The average incidence of hyper-
thyroidism was 1.7%, but ranged as high as
7% in Sweden. Any increase in iodine intake
will cause some increase in the incidence of
hyperthyroidism in a previously iodine-defi-
cient population (31,32). Most cases result
from underlying multinodular thyroid dis-
ease when autonomous nodules that are not
suppressed by increased iodine uptake pro-
duce excessive thyroid hormone (31,32).
Most of these cases resolve spontaneously
and the incidence ofhyperthyroidism drops
to presupplementation levels within a few
years. The elderly are at more risk because
they have a higher incidence ofmultinodular
goiter. In areas without endemic goiter,
hyperthyroidism as a result ofiodine is much
less common. Hyperthyroidism may also be
induced in people with Graves disease, espe-
cially after antithyroid therapy, and in
approximately 2% of patients taking amio-
darone (33) or other pharmacologic sources
of iodine. There is also concern that iodine
may induce autoimmune thyroid disease
and both papillary and follicular thyroid
cancer (1,29).
Reports of hyperthyroidism from the
ingestion of iodine used for water disinfec-
tion are rare. Liel and Alkan (34) reported
on two travelers who became hyperthyroid,
presumably because of using iodine tablets
for water disinfection. Both were from
iodine-sufficient areas and tested positive for
antithyroid peroxidase antibodies and nega-
tive for antithyroglobulin antibodies. The
mother and sister ofone ofthe travelers had
Hashimoto thyroiditis (34). The course of
the thyroid dysfunction for both travelers
was relatively mild and self-limited.
A female Swiss traveler developed mild
and reversible hyperthyroidism after using
iodine for water purification. The traveler
had a previous hemithyroidectomy for a non-
toxic nodule, had evidence of autoimmune
disease, and tested positive for antithyroid
peroxidase antibodies. The traveler's transient
hyperthyroidism was followed briefly by sub-
clinical hypothyroidism but reverted to
euthyroid status a few months later, when
her iodine intakewas reduced (35).
Iodine-induced hypothyroidism and/or
goiter. Hypothyroidism from excessive
iodine intake is much more common than
hyperthyroidism. Hypothyroidism is attrib-
uted to the prolonged suppression ofthyroid
hormone production as the result of excess
iodine levels, but the mechanism through
which iodide goiter is produced is not well
understood (36,37). Apparently, patients
with iodide goiter require less iodide to
inhibit the organic binding ofiodine and do
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not escape the inhibitory effects ofiodides as
do those who do not develop goiter (38,39).
The problem may result from the thyroid
gland's inability to limit the uptake ofiodine
when large amounts are available, after
which the accumulated iodine inhibits the
synthesis of hormone (36). Histologic stud-
ies suggest that many people who develop
iodide goiter have underlying thyroid disease
(40). Iodine-induced hypothyroidism or goi-
ter is more common in several groups but
may occur with or without underlying thy-
roid disease. The following people are at
increased risk for iodine-induced hypothy-
roidism (5,28,37,41):
* those with underlying thyroid problems,
including current or prior thyroiditis, pre-
vious treatment for Graves disease, previ-
ous subtotal thyroidectomy for benign
nodules, and previous treatment with
interferon-ct
* fetuses, preterm neonates, and newborn
infants who are at risk because of the pla-
cental transfer of iodide from mothers
treated with iodides
* those with endemic goiter due to very high
dietary iodine intake-mainly described in
coastal areas ofJapan
* thosewith other conditions, including
-elderly people without clinical thyroid
disease who may have subclinical
hypothyroidism (i.e., elevated TSH but
normal free T4 levels) (subclinical
hypothyroidism is very common, affect-
ing 5-10% ofadults over the age of50)
-patients with certain nonthyroid diseases
such as chronic dialysis and cystic fibro-
sis, especially those taking sulfasoxazole
-patients taking medications containing
iodine, formerly iodide expectorants but,
more recently, amiodarone
-patients taking lithium
-people with a family history of goiter or
thyroiditis (suggested by a few case
reports).
Excess iodine ingestion may be causally
related to autoimmune thyroid disease (1,5).
However, a recent study ofJapanese subjects
who excreted an average of 1.5 mg/day
iodine in their urine demonstrated no corre-
lation between antithyroglobulin antibodies
or hypothyroidism and levels of urinary
iodine (42).
There are three types of reports and
studies of iodine-induced hypothyroidism
and goiter: case reports, cross-sectional stud-
ies of cohorts with high iodine intake, and
experimental studies. Case reports help eluci-
date the natural history and pathophysiology
ofhypothyroidism, but do not have a popu-
lation-time denominator to determine the
incidence (19,36,38). Paris et al. (38) dis-
cussed 11 patients with iodide goiter that
developed after a minimum of 13 months of
ingesting high but unspecified amounts of
iodide for asthma. The patients' iodine
uptake by the thyroid rapidly recovered
when they stopped taking iodide. In one
patient who resumed taking iodide after the
goiter had resolved, the goiter reappeared
within 5 weeks. Harrison (36) studied four
patients with iodide goiters who had been
taking iodine for asthma in doses of
24-1,270 mg/day for 4-13 years. Their goi-
ters resolved spontaneously after they stop-
ping taking iodine.
In the few cross-sectional population
studies reporting iodine-induced goiter, the
incidence of goiter is variable and does not
correlate well with the quantity of iodine or
with the level of hypothyroidism. In some
coastal regions ofJapan, residents who eat a
traditional diet rich in seafood and seaweed
have an average iodine intake of 1-5
mg/day, with some residents consuming as
much as 20-40 mg/day. A few people devel-
oped goiters at this intake level (39>43).
Those who ingested 3-16 mg/day iodine
had a 10% incidence of goiter, but clinical
hypothyroidism in this population was rare
(43,44).
Mu et al. (45) found that > 60% of
school children in central China developed
goiter from ingesting water with natural
iodine content of462 pg/L and that all were
clinically euthyroid. Assuming they ingested
an average of2 L water/day, this is the lowest
documented iodine dose to produce goiter,
even accounting for the lower bodyweight of
the children. In this study, estimated intake
was not specified and other dietary sources of
iodine were not excluded. In another study,
44 (46%) Peace Corps volunteers who
ingested an average of at least 50 mg iodide
per day over a period of up to 1 year (from
the use ofiodine resins forwaterdisinfection)
had enlarged thyroids, but 68% ofthese had
normal thyroid function tests (20).
Amiodarone, used for serious cardiac
dysrhythmias, contains 37% organic iodide
by weight that releases 9-10 mg free iodine
from a 300-mg dose. Various investigators
have reported an incidence of hypothy-
roidism of2-10% among American patients
taking amiodarone (33). The pathophysio-
logic mechanism by which amiodarone leads
to iodine-induced goiter may include the
inducement of antithyroid antibodies and
direct effects of the medication rather than
simple suppression by iodine (32,39,46).
Among patients taking amiodarone, goiter
was present in 60% ofhypothyroid patients
and 39% of euthyroid patients in Italy and
in 22% ofhypothyroid patients and 17% of
euthyroid patients in the United States (46).
The difference in goiter rates may be related
to mild underlying iodine deficiencies in the
Italian patients.
Human experimental studies provide the
best dose-response data, but most are oflim-
ited duration (Table 2). In several recent
studies, researchers administered approxi-
mately 30 mg iodine/day for 1-12 weeks to
healthy volunteers. The results of all studies
showed that patients had statistically signifi-
cant increases in TSH levels, but only some of
the patients showed significant decreases in
levels ofT3 and T4. However, despite these
changes, TSH, T3, and T4 levels remained
within the normal range and rapidly reverted
to normal when patients stopped taking the
iodine supplements (49,51-54). In two of
the studies, researchers also found that thy-
roid volume increased (52,54). In both stud-
ies, thyroid size rapidly reverted to normal
after cessation of excess iodine. Studies
administering even higher doses ofiodine to
subjects obtained similar results (47,51,55).
Paul et al. (56) looked at the minimum dose
that would cause alterations in thyroid func-
tion and found that 1,500 pg/day increased
TSH levels whereas 500 and 750 pg/day did
not. None ofthese experimental studies fol-
lowed patients long enough to detect clinical
hypothyroidism or goiter.
The basis for existing recommendations
of maximum safe intake level of iodine are
studies by Freund et al. (48) and Thomas et
al. (57), who iodinated the water to three
Florida prisons. They found minimal
changes and no clinical problems when
water with 1 mg/L iodine was provided to
prisoners for up to 3 years. However, prison-
ers given water containing 5 mg/L iodine for
2 months had a significant decrease in iodine
uptake and serum protein-bound iodine.
After the addition of 1 mg/L iodine in
prison water for 15 years, the investigators
did not find any subjects in whom the use of
iodinated water caused a decrease in serum
concentrations of thyroxine below normal
values, and they did not find any instances
of allergic reactions. In addition, there were
no instances of neonatal goiter in 181 full-
term infants born to women who were incar-
cerated while pregnant and who delivered
their infants while in prison (48).
Morgan and Karpan added 12-19 mg/L
iodine to the water supply of a military base
for 26 weeks and reported no evidence of
altered thyroid activity or other abnormali-
ties. Unfortunately, the only published report
oftheir study (50) contains no details oftheir
results, and the original data are not available
Other toxic effects ofiodine. In a recent
review of toxic effects of iodine, Pennington
(58) found that sensitivity reactions including
rashes and acne may occur with usual supple-
mentation levels ofiodine. Given the necessi-
ty ofiodine, it is not clear why some people
react to certain forms of the substance, such
as the iodine in salt. Extrathyroidal side
Environmental Health Perspectives * VOLUME 1081 NUMBER 81 August 2000 681Commentary * Backer and Hollowell
Table 2. Summary table of experimental evidence
for iodine use in drinking water.
Iodine
dose/day Time Person-
(mg) Subjects (days) weeks Ref
Low dose 16,666
1.5*8 8 14 16 (47)
2-4b 29-133 37 months 16,640 (48)
g*,a 4 17 10 (49)
Intermediate dose 878
10-15b 70 60 630 (48)
(2 months)
12-20c NS 182 NS (50)
(26 weeks)
10-20d 4 90 52 (48)
20-30** 12 14 24 (51)
25*,a 11 28 44 (39)
27*8a,e 10 30 17 (52)
32*,a 7 7 7 (53)
32*,a,e 8 90 104 (54)
High dose 113.5
70*,a,f 14 14 28 (51)
1,140*a 4 80 44 (47)
72*,a 10 11 15 (55)
3609 9 12-19 18 (55)
1ooh 5 12 8.5 (25)
Low, intermediate, and high dose defined as 1-10, 10-35,
and > 35 mg/day, respectively. NS, not specified, but
included all personnel on a military base.
"All values remained within clinical measures of normal
limits. bSmall increase in protein-bound iodine, decrease
in iodine uptake, T4 unchanged. CNo values given: "No
evidence of altered thyroid activity.' dOne subject devel-
oped subclinical hypothyroidism and one developed sub-
clinical hyperthyroidism. *Measured thyroid volume
increased but no goiter was apparent. fl.0 mg/kg/day.
9One subject developed subclinical hypothyroidism (TSH
above normal range). 1'Three of five subjects developed
subclinical hypothyroidism (TSH above normal range).
*Statistically significant change in TSH, with or without
change inT3 orT4. **Changes in TSH,T3, and T4were not
statistically significant.
effects of iodine include gastrointestinal
(nausea, epigastric pain, and diarrhea),
sialadenitis, and iodide fever. These toxic
reactions require large doses of iodide, but
dose-response relationships have not been
established (59). It is unclear whether skin
rashes and conjunctivitis are toxic or allergic
reactions. lodism refers to a chronic toxicity
that occurs in all individuals when given
iodine in suficiently high doses over a long
enough period of time-but the required
dose and duration are highly individual.
Symptoms resemble a sinus cold with gas-
trointestinal upset and acneform skin
lesions, all of which resolve spontaneously
when excess intake stops (60).
Dose response, threshold level, and sig-
nificance ofchanges. Given the physiologic
activity of iodine and marked individual
sensitivity, especially in iodine-deficient pop-
ulations or those with underlying thyroid
disease, it is difficult to delineate a no-effect
level, even for limited duration exposures.
On the other hand, most people can tolerate
pharmacologic doses ofiodine for years with
no ill effect (5). The reported incidences of
goiter, hypothyroidism, and hyperthyroidism
vary so widely that they cannot be used to
derive clear dose limits. Wolff(37) reviewed
reported cases ofiodide goiter and condud-
ed that large amounts ofiodine (from 18 mg
to > 1 g/day) were required for prolonged
periods (< 6 months in a few cases but . 5
years of iodide therapy in many cases).
Pennington (58) reviewed case reports to
evaluate the levels at which oral doses of
iodine cause adverse effects, and found that
49 people from 15 reports had adverse
effects from iodine intakes < 10 mg/day,
including 19 with hyperthyroidism, one
with goiter, and one with sensitivity reac-
tion. Some ofthese individuals had underly-
ing thyroid disease. Single 100-mg doses of
potassium iodide for thyroid protection after
a nuclear accident caused infrequent and
mild extrathyroidal side effects and no long-
term thyroid changes (61).
Experimental data (Table 2) suggest that
. 1.5 mg/day iodine will cause statistically
significant changes in thyroid hormone
assay. However, these changes are not clini-
cally significant, so they questionably consti-
tute a valid threshold effect level. Even at
much higher doses the changes in thyroid
function remain subclinical; that is, TSH
levels were elevated butT4 levels were within
the normal range. Subclinical abnormalities
in thyroid function are commonly identified
by serologic diagnostic batteries, especially in
elderly people, yet the significance and need
for treatment are debated despite the persis-
tence of these abnormalities in this popula-
tion (62-64). In contrast, human experiments
of iodine ingestion in healthy volunteers
demonstrated reversible changes in thyroid
function and goiter (47,51,52,54). Clinical
hypothyroidism is rare amongJapanese with
endemic goiter due to long-term ingestion of
excess iodine. In these cases, both thyroid
function and thyroid size return to normal
when excess iodine consumption is stopped,
unless underlying thyroid disease is present
(36,38,39,43).
The 10th edition of the Recommended
Dietary Allowances, published in 1989 (65),
suggested that the maximum allowable
dietary dose of iodine be 1.0 mg/day for
children and 2.0 mg/day for adults. These
recommended limits were increased from
1.0 mg/day for adults in the previous
(1980) edition (58,66) based primarily on
the data from Freund et al. (48) and
Thomas et al. (57). The National Academy
of Sciences reached a similar conclusion by
calculating a suggested no-adverse-response
level from toxicity data (11), and noted that
this was consistent with the data from both
Freund et al. (48) and Morgan and Karpen
(50). Most uses of iodine for field water
treatment would exceed these recommended
limits. Recommendations for short-term
emergency use of iodine are generally
limited to approximately 3 weeks [Water
and Sanitation for Health Project (67),
Zoeteman (16), and the National Academy
ofSciences (11)]. The WHO has sponsored
long-term iodination ofwater for large pop-
ulations at doses up to 0.3-0.4 mg/L to pre-
vent iodine deficiency disorder. Although
these doses may be bacteriocidal, they are
unlikely to be adequate for the destruction
of cysts and viruses. The details of adverse
reactions were not provided in a summary
report (3).
The available data suggest that neither
the maximum safe dietary dose ofiodine nor
the maximum safe period of consumption
for water treatment are firmly established.
Available data also are not adequate to define
a linear and temporal dose response between
iodine intake and thyroid function (Table
2). The strongest data suggest that low levels
of iodine (1-5 mg/day) are safe for most
people for years. It should be noted that
Freund et al. (48) supplied 1 mg/L iodine in
water, not 1 mg/day, and estimated the aver-
age daily intake as 2-4 mg/day. Well-con-
trolled experimental trials have evaluated
intermediate levels of iodine from 10 to 32
mg/day for up to 3 months. These levels
consistently cause subclinical changes in thy-
roid function, and may cause thyroid
enlargement, but clinical hypothyroidism
was not observed. The data from Georgitis
and McDermott (53) and LeMar et al. (54)
suggest that 3 months of moderately high
levels ofiodine ingestion (32 mg/day) carries
no more risk than 1 week of ingestion.
Higher levels may be well tolerated, but
Peace Corps data indicated that people who
consumed > 30 mg/day for 6 months had a
high incidence of goiter (20). In contrast,
this incidence of goiter was not noted in
populations that commonly used even high-
er doses ofiodine as an expectorant (38,68),
suggesting that some cofactor may be
required for the development ofgoiter.
Recommendations for Iodine
Use in Water Treatment
We are not advocating raising the daily min-
imum requirements of iodine, nor are we
promoting the use of iodine for routine
community water treatment in small remote
communities or in developing countries,
where there would be a higher incidence of
adverse effects. Despite alternative methods
of disinfection alternatives, iodine remains
popular for individual and small-group field
water treatment in situations where surface
water is ingested or water quality from a
distribution system is questionable. This dis-
cussion should be useful for the develop-
ment of policy and procedures for agencies
that place personnel in remote locations and
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for stimulation of policy debate at agencies
that regulate products containing iodine.
When iodine is considered the best
means of water treatment, we recommend
the following:
* Do not use an iodine-based water treat-
ment method for people with increased
susceptibility to iodine-induced thyroid
disorders
-pregnant women (fetus susceptible to
goiter)
-people with known hypersensitivity to
iodine
-people with a history of thyroid disease,
even ifcontrolled on medication
-people with a strong family history of
thyroid disease
-people from countries or localities with
chronic iodine deficiency.
* Examine the thyroid and do thyroid func-
tion tests on anyone planning to use iodine
for prolonged periods (longer than 3
months) to ensure that they are initially
euthyroid. It is not clear whether the pres-
ence of antithyroid antibodies is a con-
traindication to iodine use.
* Limit the use of water disinfection meth-
ods that produce moderately high levels of
iodine (5-32 mg/L), such as iodine tablets,
to 3 months.
* Euthyroid people can safely use iodine
treatments that produce a low residual (< 1
mg/L) level, even for long periods of time.
Current products containing iodine resin
devices with a charcoal scavenger to remove
residual iodine can meet this standardwhen
used properly. Likewise, a two-step process
of water treatment with iodine tablets or
iodine solutions, then filtration by a device
containing charcoal, can ensure safe levels
ofiodine andeffective water treatment.
* Standards are needed to ensure the efficacy
and safety of iodine-containing water
purification products intended for pro-
longed use
-the products must contain an effective
iodine scavenger (usually granular acti-
vated charcoal) sufficient to decrease the
residual to a level safe for long-term use
(years)
-the iodine scavenger must be effective
throughout the life span ofthe device or
there must be a reliable method to indi-
cate when the iodine scavenger no longer
has adsorptive capacity so that it can be
replaced
-the product must perform adequately
without the need for high levels ofresid-
ual iodine.
In summary, the use of iodine for water
disinfection requires a risk-benefit decision
similar to other medical interventions that are
used prevent illness in high-risk populations.
The pauciry of accurate water qualiry data
for most parts of the world, and known
issues ofwater quality where it is measured,
mandate additional measures to ensure
potable water in many situations (69). The
risk for enteric infection (70) and the avail-
ability of other means of producing potable
water should be weighed against the risk for
and severity ofthyroid disorder from iodine.
Enteric disease rates from water with micro-
biologic contamination may be high and
repeat infections can be anticipated because
only limited immunity develops (71). Iodine
is an effective, simple, and cost-efficient
means of water disinfection. For temporary
residents, relief workers, and travelers in
areas where municipal water treatment is not
reliable, the benefit ofuse exceeds the risk.
Although there is fair evidence that the
current recommended upper limits of daily
iodine ingestion are safe, there are limited
data to suggest that this upper limit is the
maximum safe level. Coupled with periodic
monitoring of thyroid function, techniques
that generate low levels (1-2 mg/L) ofiodine
in water can be safely used foryears.
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